Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FLAMMA | Contract Pharma

What are you searching for?

Sign in

Search by

FLAMMA

FLAMMA

Company Headquarters

Via Bedeschi 22 , Flamma Chignolo (headquarters), Chignolo d'Isola (BG), 24040, IT

Driving Directions Phone: View Phone
View website

Company Description

Award-winning FLAMMA is a family-owned CDMO built for today’s biotech innovators. We bring 75 years of chemistry excellence to GMP manufacturing of small-molecule API, NCE & RSMs. Our 5 cGMP sites (Italy 3 + China + USA; 1,300 m³) deliver a SECURE, RELIABLE supply chain with real chemistry in every partnership. Move fast. Partner with Flamma USA

Request more information from FLAMMA

Request more information from FLAMMA

Categories from FLAMMA

Analytical Methods Development
cGMP Synthesis
Clinical Trials, Phase I
Clinical Trials, Phase II
Clinical Trials, Phase III
Clinical Trials, Phase IV
CMC (Chemistry, Manfacturing & Controls)
Contract Development and Manufacturing Organization (CDMO)
Contract Manufacturing
Contract Research
Custom Manufacturing
Custom Synthesis
Drug Development Services
Manufacturing, API
Manufacturing, API, High Potency
Manufacturing, Custom
Manufacturing, Cytotoxic & High Potency Compounds
Manufacturing, Generics
Manufacturing, High Containment Operations
Manufacturing, Nutraceuticals
Manufacturing, Oligonucleotides
Manufacturing, Ophthalmics
Manufacturing, Other
Manufacturing, Peptides
Methods Development
Methods Validation
Organic Synthesis
Process Development/Scale-Up Services
Process R&D
Process Validation Studies
Project Management
QA/QC
R&D Services
Scale-Up
Stability Studies
Stability, ICH
Supplier, Fine Chemicals
Supplier, Raw Materials
Validation, Manufacturing

Related Content

Online Exclusives

Inside CPHI Milan’s New Sustainability Summit

Silvia Forroova shares how CPHI Milan’s new Sustainability Summit will bring pharma leaders together to tackle key sustainability challenges.

By: Charlie Sternberg

Breaking News

Contract Pharma Announces New Bio Outsourcing Conference in Cambridge

Two-day event will bring the biopharma outsourcing community together April 1-2, 2027.

By: Tim Wright

Promotions & Moves

Mirum Pharmaceuticals Names Rob Myers Chief Medical Officer

Myers comes from OrsoBio, where he was Chief Medical Officer as well as Head of Development.

By: Patrick Lavery

Promotions & Moves

Codis Promotes Steven Facer to Chief Commercial Officer

Facer offers 30+ years of leadership experience across pharmaceuticals, medical devices, and packaging.

By: Charlie Sternberg

Breaking News

Telix to Buy ITM in $1.65B Radiopharma Deal

The acquisition adds isotope production, manufacturing, and late-stage therapeutic assets to Telix’s radiopharmaceutical platform.

By: Charlie Sternberg

Videos

The Friday Brief for September 18, 2026: Companies Expand in US & Europe

Hovione, Upperton, Piramal Pharma, Syntegon, Evonik, and Fareva opened or announced plans to build new facilities.

By: Patrick Lavery

Trials & Filings

Quotient Sciences Reports AI Clinical Trial Milestone

Proprietary algorithm achieved a preset pharmacokinetic target during an ongoing modified-release formulation study.

By: Charlie Sternberg

Collaborations & Alliances

SK Biopharma, 1STBIO Sign Parkinson’s Drug Deal

The exclusive global licensing agreement covers 1ST-104 and includes upfront, milestone and royalty payments.

By: Charlie Sternberg

Breaking News

Piramal Pharma Plans Solar Power Plant in UK

Ground-mounted plant will generate about 3,950 MWh annually.

By: Charlie Sternberg

Collaborations & Alliances

Sanofi, UCB, Opella Join Clean Heat Program

Pharma companies back Secaro and ERM initiative to cut industrial heat emissions.

By: Charlie Sternberg

Collaborations & Alliances

Ori Biotech Lands 10-Year, $120M Commercial Cell Therapy Manufacturing Deal

The strategic collaboration was agreed upon with an undisclosed biopharmaceutical company.

By: Patrick Lavery

Breaking News

Asahi Kasei Launches VANTIJ SU-VFC Benchtop

New platform streamlines small-scale virus filtration for biopharma and gene therapy workflows.

By: Charlie Sternberg

Breaking News

Syntegon Opens OSD Customer Center in Fellbach

Offers support to pharmaceutical and nutraceutical developers from the initial idea through to series production.

By: Charlie Sternberg

Promotions & Moves

SonoThera Appoints Adam Shaywitz Chief Medical Officer

Shaywitz brings two decades of experience in the biopharmaceutical industry, most recently at BridgeBio.

By: Patrick Lavery

Collaborations & Alliances

Samsung Biologics Signs $262M Manufacturing Deal With European Pharma Company

The agreement extends manufacturing commitments through 2033 and pushes Samsung Biologics’ cumulative contract value above $21.9 billion.

By: Charlie Sternberg